The whole body of work

Clinical Precision Oncology Consultation A structured discussion of the molecular and clinical picture in a cancer case, and of the questions it raises. Clinical Molecular Report Review A detailed reading of a next-generation sequencing or molecular profiling report, including what the assay could and c… Clinical Cancer Second Opinion An independent re-reading of the clinical, pathological and molecular record in a complex case. Clinical Precision Oncology Analysis & Strategy The flagship service: a structured review of the clinical, pathological, molecular and evidentiary dimensions of a com… Clinical Molecular Tumour Board Review Multidisciplinary review of a case with molecular findings at the centre of the discussion. Clinical Clinical Trial Matching Identification of trials whose scientific rationale and eligibility criteria plausibly fit a specific case. Clinical Cancer Genetics & Hereditary Risk Review Review of germline findings and family history, and of what they may mean for the patient and their relatives. Clinical ctDNA / Liquid Biopsy Review Interpretation of circulating tumour DNA results, including their limits. Clinical Longitudinal Molecular Monitoring Interpretation of molecular change over time rather than at a single point. Clinical Complex Case Review Extended review of cases where the clinical, pathological and molecular picture do not straightforwardly agree. Research Cancer Genomics Most molecular reports return more findings than are decision-relevant. Separating the consequential from the incident… Research Tumour Evolution A tumour at relapse is often not the tumour that was profiled at diagnosis. Treating disease as a fixed molecular obje… Research ctDNA & Liquid Biopsy ctDNA is genuinely informative in specific, bounded situations. Being precise about which situations those are is more… Research Single-Cell Biology Bulk measurements describe a mixture. Where the mixture itself is the biological question — immune infiltration, resis… Research Multi-Omics A DNA-level finding often only becomes interpretable when read against expression, methylation or protein evidence fro… Research Biomarker Discovery The gap between a marker that separates groups in a discovery set and one that holds up elsewhere is where most candid… Research AI in Oncology The useful question is not whether a model performs well on a benchmark, but whether its output changes a decision and… Research Clinical NLP Most of the clinically important record — pathology narrative, clinic letters, the literature itself — is prose. Struc… Research Clinical Trial Matching The failure mode in trial search is rarely finding nothing. It is finding a long, undifferentiated list in which relev… Research Computational Oncology Interpretation that cannot be reproduced six months later is difficult to audit, difficult to improve and difficult to… Research Pharmacogenomics Toxicity risk is part of a treatment decision, not a separate conversation. Some of it is predictable from the germlin… Research Clinical Decision Support Decision support that cannot show its reasoning is difficult to challenge — and a system that cannot be challenged is … Research Rare Cancer Biology Rare cancers are not simply under-studied common cancers. They require a different information architecture, because t… Technology ExplainMyMutations.AI Patients and clinicians increasingly hold molecular reports that are technically complete but difficult to interpret. … Technology Structured molecular tumour board framework Molecular tumour board discussions vary widely in structure, and the reasoning behind a recommendation is often not re… Record 17 International awards Awards and recognitions received at international scientific meetings and from international bodies. Record 57+ Publications Peer-reviewed articles, preprints and review work across oncology, computational biology and translational research. Record 47+ Intellectual properties Granted patents and filed applications across therapeutics, medical devices, biotechnology and engineering. Record 5+ Books Long-form scientific writing across statistics, analytical methods and biomedical protocols. Memberships Fellow of the Royal Society of Medicine Royal Society of Medicine Memberships Member of the Royal Society of Biology Royal Society of Biology Memberships Member, International Society for Computational Biology International Society for Computational Biology (ISCB) Memberships Associate credential, Board of Genetic Counseling India Board of Genetic Counseling India Education PhD — Doctor of Philosophy Awarded on the basis of independent original research Education PhD (hon) — Honorary doctorates Conferred as honorary distinctions Education MSc — Cancer Genomics and Data Sciences Barts Cancer Institute, Queen Mary University of London Education Foundational Diploma in Medicine Foundation-level academic diploma Education Undergraduate Diploma Undertaken across Indian and United States institutions Education BSc — Bachelor of Science Biological sciences Education Academic and research association Newcastle University Media FOX59 Television · Cancer research and precision oncology Media CBS42 Television · Cancer research and precision oncology Media Manav Rachna University Academic Event · Cancer genomics and computational biology Media DASL Podcast Podcast · Precision oncology, genomics and artificial intelligence Speaking AI in Oncology What artificial intelligence can realistically contribute to cancer care, and where enthusiasm has outrun evidence. Speaking Precision Oncology How molecular, clinical and evidentiary information are brought together around a single treatment decision. Speaking Cancer Genomics What sequencing a tumour does and does not tell you, and how to read a molecular report critically. Speaking Clinical Intelligence Turning fragmented cancer data into information that is usable at the point of decision. Speaking Rare Cancer Why rare cancers need a different information architecture, not simply more of the usual research. Speaking Liquid Biopsy Where circulating tumour DNA genuinely adds value, and where it adds a number without adding information. Speaking Tumour Evolution How tumours change under treatment pressure, and what that means for sequencing therapy. Speaking Clinical Trial Matching Why finding a relevant trial is a different problem from finding a trial. Speaking Computational Biology The methods underlying modern molecular analysis, and how method choice shapes conclusions. Speaking Biomedical AI Designing machine learning systems for medicine that clinicians can interrogate rather than merely obey. Speaking The Future of Cancer Care How molecular evidence, clinical expertise and computational systems might work together around the individual patient… Speaking Genomics in India Building genomic and precision oncology capability in the Indian healthcare context.